RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Research Alliance Corp III
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$10.23+0.07 (+0.69%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for Research Alliance Corp III.